Like RxSolutions

closed 1/17/2019 via Company Press Release

TrialCard, acquired RxSolutions

synopsis: TrialCard, a company that offers customized patient access solutions exclusively for the pharmaceutical industry, has acquired RxSolutions, a privately-held company specializing in customized pharmaceutical reimbursement-based programs for both the marketing and clinical supply professional.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard offers customized patient access solutions exclusively for the pharmaceutical industry in support of product marketing, patient assistance programs, and phase IV clinical trials. TrialCard innovates by focusing on client brands and analyzing new trends in prescription optimization. "
target: RxSolutions
RxSolutions is a privately-held company with more than 20 years experience specializing in customized pharmaceutical reimbursement-based programs for both the marketing and clinical supply professional. They are known for their dedication to customer care at a remarkable value.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/14/2007 via PR Newswire

Global Healthcare Exchange, LLC, acquired Market4care

synopsis: Market4care, the largest provider of e-procurement and other supply chain services to hospitals and healthcare suppliers in the Netherlands, has joined GHX, LLC (GHX) under an acquisition announced today.
buyer: Global Healthcare Exchange, LLC
Global Healthcare Exchange, LLC (GHX) has created an open and neutral Internet-based trading exchange, along with additional value-added products and services, to reduce costs and improve efficiencies for all participants in the healthcare supply chain. "
target: Market4care
Market4care currently serves more than 20 percent of all Dutch hospitals, providing them with the ability to send and receive electronic transactions. The company's catalog management service contains more than 30 million items from more than 220 multinational and regional suppliers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/1/2007 via PR Newswire

Wellpoint Health Networks, Inc., acquired American Imaging Management, Inc.

synopsis: WellPoint, Inc. the nation's leading health benefits provider, today announced the completion of its acquisition of American Imaging Management, a leading radiology benefit management and technology company.
buyer: Wellpoint Health Networks, Inc. (ANTM:$88,026.30)
WellPoint, Inc. is the largest health benefits company in terms of commercial membership in the United States. Through its nationwide networks, the company delivers a number of leading health benefit solutions through a broad portfolio of integrated health care plans and related services. "
target parent: Nautic Partners, LLC
target: American Imaging Management, Inc.
American Imaging Management, Inc. is a leading company in the radiology benefit management industry. AIM promotes the appropriate use of diagnostic imaging through the application of widely accepted clinical guidelines delivered through an innovative platform of technologies and programs.
price ($mm)
$300
rev ($mm)
$200
EBITDA ($mm)
EV / rev
1.5x
EV / EBITDA
closed 12/19/2018 via Company Press Release

Change Healthcare Corporation, acquired PokitDok Inc.

synopsis: Change Healthcarehas acquired intellectual property (IP) and other key assets from PokitDok, Inc., a platform-as-a-service company for healthcare. PokitDok’s platform-as-a-service makes it faster and easier for healthcare organizations to bring new applications and services to market.
buyer parent: McKesson Corporation
buyer: Change Healthcare Corporation
Change Healthcare is inspiring a better healthcare system. Working alongside their customers and partners, they leverage their software and analytics, network solutions, and technology-enabled services to enable better patient care, choice, and outcomes at scale. "
target: PokitDok Inc.
PokitDok’s platform-as-a-service makes it faster and easier for healthcare organizations to bring new applications and services to market. Plug directly into over 700 payers to integrate real-time, member-specific health insurance data at scale.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/17/2019 via BNC Analysis

J.P. Morgan Chase & Co., acquired InstaMed

synopsis: As part of its efforts to accelerate its activity in the payments processing space, JPMorgan Chase has purchased healthcare payments technology company InstaMed. InstaMed has developed a cloud-based platform to coordinate bill payments between providers, insurers and patients.
buyer: J.P. Morgan Chase & Co. (JPM:$104,870.00)
JPMorgan Chase & Co. is a leading global financial services firm with assets of $2.7 trillion and operations worldwide. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. "
target: InstaMed
InstaMed is healthcare’s most trusted payments network, connecting providers, payers and consumers on one platform. The InstaMed Network connects over two-thirds of the market and processes tens of billions of dollars in healthcare payments annually.
price ($mm)
$500
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/15/2015 via BusinessWire

Global Payments, Inc., will acquire Heartland Payment Systems

synopsis: Global Payments Inc., a leading worldwide provider of payment technology services, announced that it has entered into a definitive agreement to acquire Heartland Payment Systems, Inc., one of the nation's largest payment companies. Heartland delivers credit/debit/prepaid card processing and security technology through Heartland Secure.
buyer: Global Payments, Inc. (GPN:$3,454.43)
Global Payments Inc. is a leading worldwide provider of payment technology services that delivers innovative solutions driven by customer needs globally. They provide a range of products and services that allow their customers to accept all payment types across a variety of distribution channels. "
target: Heartland Payment Systems (HPY:$2,682.40)
Heartland Payment Systems, Inc., one of the largest payment processors in the United States, delivers credit/debit/prepaid card processing and security technology through Heartland Secure™ and its comprehensive breach warranty.
price ($mm)[EV]
$3,857 [$4,312]
rev ($mm)
$2,588
EBITDA ($mm)
$202
EV / rev
1.7x
EV / EBITDA
21.8x
closed 6/18/2013 via Market Wire

PaySpan, Inc., acquired mPay Gateway Inc.

synopsis: PaySpan Inc., the leading provider of healthcare payment and reimbursement automation, announced the acquisition of the assets of mPay Gateway, a point-of-service patient payment solution for healthcare providers.
buyer parent: ABS Capital Partners, L.P.
buyer: PaySpan, Inc.
PaySpan, Inc., with more than 25 years of payments expertise, is a trusted source of innovative healthcare reimbursement solutions, empowering the healthcare economy for health plans, providers, members and banks. "
target: mPay Gateway Inc.
mPay Gateway is a PCI certified acquiring card processor, delivering bankcard solutions with integrated web based management software to Providers that addresses the increased cost of collecting from consumers enrolled in consumer directed health care plans.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/16/2013 via BusinessWire

TOT Money, acquired Unified Payments

synopsis: Net Element International, and Unified Payments, a leading provider of transaction processing services and payment-enabling technologies announced that they have entered into a binding term sheet for Net Element International to acquire Unified Payments and operate it through its newly formed subsidiary, TOT Money.
buyer parent: Net Element, Inc.
buyer: TOT Money
TOT Money is a mobile payment processor and mobile commerce provider that facilitates the payment, aggregation and distribution of mobile transactions. Their clients include wireless carriers, content providers and merchants. "
target: Unified Payments
Unified Payments, which has been recognized by Inc. Magazine as the fastest-growing private company in America in 2012, is a leading socially responsible provider of transaction processing services and payment-enabling technologies to small, medium, and large merchants across the United States.
price ($mm)
$24
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2018 via PR Newswire

Carrick Capital Partners, LLC, acquired Discovery Health Partners

synopsis: Carrick Capital Partners, an investment firm focused on technology-enabled services including Software announced the close of an additional significant investment in Discovery Health Partners. Discovery Health Partners helps organizations reduce and contain healthcare spend through intelligent cost containment solutions.
buyer: Carrick Capital Partners, LLC
Carrick Capital Partners is an investment firm that utilizes ABV (Approach to Building Value) to operationally scale fast growing businesses that provide software and technology-enabled services. "
target parent: LaunchPoint
target: Discovery Health Partners
Discovery Health Partners helps organizations reduce and contain healthcare spend through intelligent cost containment solutions. They are specialists in technology, services, and solutions for Subrogation, Coordination of Benefits, Dependent Eligibility Verification, and Healthcare Analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/2/2018 via PR Newswire

Thoma Bravo, LLC, acquired ABC Financial Services, Inc.

synopsis: Thoma Bravo, a leading private equity investment firm, announced that it has completed its acquisition of ABC Financial Services, Inc., a software and payment processing company servicing more than 6,700 health clubs throughout North America.
buyer: Thoma Bravo, LLC
Thoma Bravo is a leading private equity firm focused on the software & technology-enabled services sectors. They implement operating best practices, invest in growth initiatives & make accretive acquisitions intended to accelerate revenue & earnings, with the goal of increasing the business’ value. "
target: ABC Financial Services, Inc.
Launched in 1981, ABC Financial has revolutionized software and payment processing for the health and fitness industry. The company's innovative club management software, DataTrak, is the most complete web-based software in the health and fitness industry.
price ($mm)
rev ($mm)
$179
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 7/18/2017 via GlobeNewswire

Ability Network, Inc., acquired Secure Bill Pay

synopsis: ABILITY® Network announced its acquisition of Secure Bill Pay, a leader in the fast-growing healthcare payment software market. Secure Bill Pay provides an all-in-one set of tools to enable providers to facilitate patient payment throughout the revenue cycle.
buyer parent: Summit Partners
buyer: Ability Network, Inc.
ABILITY® Network is a leading information technology company that helps providers and payers simplify the administrative and clinical complexities of healthcare through innovative applications and data analytics. "
target: Secure Bill Pay
Hospitals, clinics and other health care providers are paid faster and easier with Secure Bill Pay's comprehensive patient payment solutions. Real-time data access with unlimited reporting, export/import or even full interface ensures payments are posted to patient accounts timely and accurately.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2004 via PR Newswire

Affiliated Computer Services, Inc., acquired Patient Accounting Service Center, LLC

synopsis: ACS ACS, a premier provider of business process outsourcing (BPO) and information technology solutions, announced today that it has acquired Patient Accounting Services Center, LLC (PASC), the industry leader in revenue cycle management in the healthcare provider industry, including billing, accounts receivables, and collections services.
buyer: Affiliated Computer Services, Inc.
Affiliated Computer Services, Inc., a global FORTUNE 500 company with 74,000 people supporting client operations reaching 100 countries, provides business process outsourcing and information technology solutions to world-class commercial and government clients. "
target: Patient Accounting Service Center, LLC
Patient Accounting Service Center, LLC (PASC) is a full-service accounts receivable management firm focused purely on healthcare reimbursement services. With more than 1000 employees, PASC provides comprehensive outsourced healthcare reimbursement services. PASC specializes in large-volume accounts
price ($mm)
$94
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/17/2019 via Company Press Release

TrialCard, acquired RxSolutions

synopsis: TrialCard, a company that offers customized patient access solutions exclusively for the pharmaceutical industry, has acquired RxSolutions, a privately-held company specializing in customized pharmaceutical reimbursement-based programs for both the marketing and clinical supply professional.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard offers customized patient access solutions exclusively for the pharmaceutical industry in support of product marketing, patient assistance programs, and phase IV clinical trials. TrialCard innovates by focusing on client brands and analyzing new trends in prescription optimization. "
target: RxSolutions
RxSolutions is a privately-held company with more than 20 years experience specializing in customized pharmaceutical reimbursement-based programs for both the marketing and clinical supply professional. They are known for their dedication to customer care at a remarkable value.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/11/2019 via PR Newswire

TrialCard, will acquire Mango Health

synopsis: TrialCard, a company that provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers, announced it will acquire Mango Health, the leading provider of mobile-based medication management and adherence solutions for the life sciences sector.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard Incorporated provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers. TrialCard has connected over 30 million patients with nearly $12 billion in branded drug savings to date. "
target: Mango Health
Mango Health is the leading digital medication management platform. It provides a critical support tool to help patients manage medications, stay on track, and have fun in the process. For payers, the platform provides a crucial window into patients' daily lives and a platform for interventions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/17/2019 via Company Press Release

TrialCard, acquired RxSolutions

synopsis: TrialCard, a company that offers customized patient access solutions exclusively for the pharmaceutical industry, has acquired RxSolutions, a privately-held company specializing in customized pharmaceutical reimbursement-based programs for both the marketing and clinical supply professional.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard offers customized patient access solutions exclusively for the pharmaceutical industry in support of product marketing, patient assistance programs, and phase IV clinical trials. TrialCard innovates by focusing on client brands and analyzing new trends in prescription optimization. "
target: RxSolutions
RxSolutions is a privately-held company with more than 20 years experience specializing in customized pharmaceutical reimbursement-based programs for both the marketing and clinical supply professional. They are known for their dedication to customer care at a remarkable value.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2013 via BNC Analysis

DrugDev, acquired CFS Clinical

synopsis: DrugDev, an interactive network and data sharing platform for over 80,000 clinical trial doctors in 93 countries, announced its acquisition of CFS Clinical (CFS), the leading specialty provider focused on the business and financial management activities for clinical trials.
buyer: DrugDev
DrugDev helps the clinical trials industry run faster, cheaper and smarter trials. Experienced Investigators choose to be part of the free network to access new clinical trial opportunities they would not otherwise have learnt about. "
target: CFS Clinical
CFS Clinical (CFS) is a technology-enabled service provider focused on the business and financial management activities for clinical trials.CFS’ experts deliver best-in-class Investigator site payment and study startup solutions around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/13/2016 via BusinessWire

Vitruvian Partners LLP, acquired Phlexglobal

synopsis: Phlexglobal, the thought leaders and specialists in the provision of electronic Trial Master File systems and services to the life sciences industry, announced an investment by Vitruvian Partners. The transaction establishes Vitruvian as majority shareholder of Phlexglobal, while previous majority investor Bridgepoint will exit the company.
buyer: Vitruvian Partners LLP
Vitruvian Partners is an independent European private equity firm that invests in high-growth Dynamic Situations. They focus on asset-light companies in targeted sectors with strong, sustainable growth, and in companies driven by new competitive advantage, a transition in business model, or events. "
target parent: Bridgepoint
target: Phlexglobal
Phlexglobal is a specialist provider of technology-enabled, Trial Master File (TMF & eTMF) document management solutions and other support services to the global clinical research market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/14/2014 via Company Press Release

Bridgepoint, acquired Phlexglobal

synopsis: Phlexglobal, the specialist provider of technology-enabled document management solutions and other support services to the global clinical research market, has been acquired by Bridgepoint Development Capital from Inflexion in a transaction totalling £42 million.
buyer: Bridgepoint
Bridgepoint is one of the most experienced private equity investment firms based in Europe. With a clear, long-term focus on sectors where it can invest in robust middle market companies, it typically acquires businesses valued between €200 million and €1 billion. "
target parent: Inflexion Private Equity Partners LLP
target: Phlexglobal
Phlexglobal is a specialist provider of technology-enabled, Trial Master File (TMF & eTMF) document management solutions and other support services to the global clinical research market.
price ($mm)
$72
rev ($mm)
$25
EBITDA ($mm)
$7
EV / rev
2.8x
EV / EBITDA
9.6x
announced 7/18/2012 via BusinessWire

Adjility Health will be merged with Alliance Life Sciences Consulting Group, Inc,

synopsis: Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, and Adjility Consulting, a consulting firm specializing in management consulting and analytic solutions for clinical operations and the global market access, pricing and reimbursement space, announced that the two companies will merge.
buyer: Alliance Life Sciences Consulting Group, Inc
Alliance Life Sciences Consulting Group employs more than 175 professionals who collectively understand the business challenges of the Life Sciences industry and offer solutions for Sales & Marketing, Managed Care & Government Contracting, Commercial Operations, Information Management and Analytics."
target: Adjility Health
Adjility Health is dedicated to helping healthcare companies improve their operations through the use of strategic consulting services and very industry domain-specific analytic, forecasting, predictive trending and other data insight tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/26/2012 via BusinessWire

Accenture, acquired Octagon Research Solutions, Inc.

synopsis: Accenture completed its acquisition of Octagon Research Solutions, a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry. The acquisition enhances Accenture's existing clinical services capabilities – including clinical data management, clinical programming and safety case processing.
buyer: Accenture (ACN:$43,215.01)
Accenture is a global management consulting, technology services and outsourcing company. Accenture collaborates with clients to help them become high performance businesses and governments. "
target parent: Edison Ventures
target: Octagon Research Solutions, Inc.
Octagon Research Solutions is the world leader in clinical and regulatory information management solutions to the life sciences industry. Through an integrated suite of outsourced services, strategic consulting, and innovative technology, Octagon optimizes the entire drug development lifecycle.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$9,474.88)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
closed 12/16/2016 via PR Newswire

Indegene Lifesystems Pvt Ltd., acquired Wincere, Inc.

synopsis: Indegene, a global healthcare solutions provider, announced the acquisition of Wincere Inc. Wincere is a leading clinical data management and clinical and statistical programming solutions provider located on the West Coast in Silicon Valley, CA. Wincere is deeply engaged with clinical R&D needs of many emerging biopharma companies.
buyer: Indegene Lifesystems Pvt Ltd.
Indegene enables global healthcare organizations to address complex challenges by seamlessly integrating analytics, technology, operations and medical expertise and drives better health and business outcomes. "
target: Wincere, Inc.
Wincere provides smarter clinical research services across all clinical trial phases by using its patent-pending technology to support clinical trial startup, conduct, and submission activities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/27/2018 via Company Press Release

The WIRB-Copernicus Group, acquired ACI Clinical

synopsis: WIRB-Copernicus Group, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, has acquired ACI Clinical, a specialty provider of clinical trial committees and clinical trial advisory services.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: ACI Clinical
ACI Clinical is a specialty provider of clinical trial committees and clinical trial advisory services. ACI Clinical specializes in clinical and safety consulting, including full service Endpoint Adjudication Committees and Data Monitoring Committees.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2014 via BNC Analysis

Synchrogenix Information Strategies, Inc. merged with Certara,

synopsis: Arsenal Capital Partners have acquired Synchrogenix Information Strategies Inc., which will merge with Certara LP. Synchrogenix, a specialty contract research organization providing strategic regulatory writing and related services to pharmaceutical, biotechnology, and medical device companies worldwide.
buyer parent: Arsenal Capital Partners
buyer: Certara
Certara™ is dedicated to improving human health through a broad spectrum of software products and services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. "
target: Synchrogenix Information Strategies, Inc.
Synchrogenix is a specialty contract research organization providing strategic regulatory writing and related services to pharmaceutical, biotechnology, and medical device companies worldwide. The company offers pre-clinical, clinical, CMC, and drug safety writing and submission services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/4/2013 via PR Newswire

Accelera Innovations, Inc., will acquire Behavioral Health Care Associates, Ltd.

synopsis: Accelera Innovations, Inc., a provider of cloud based software-as-a-service solutions to the healthcare industry announced that they have signed a stock purchase agreement to acquire 100% of Behavioral Health Care Associates, Ltd., a provider of billing, practice management and administrative services to doctors and other clinicians.
buyer: Accelera Innovations, Inc.
Accelera Innovations, Inc. offers cloud based software-as-a-service solutions to the healthcare industry that includes technology and services to providers and payers, who are seeking to create an interoperable technology platform that is patient-centric. "
target: Behavioral Health Care Associates, Ltd.
Behavioral Health Care Associates, Ltd. provides billing, practice management and administrative services to doctors and other clinicians who provide services to hospitals, nursing homes and individual clients.
price ($mm)
$4.55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/20/2012 via PR Newswire

ePharmaSolutions, Inc., acquired Polaris Biopharma Consulting

synopsis: ePharmaSolutions announced the acquisition of Polaris BioPharma Consulting, a leading global patient recruitment and retention firm headquartered in Slough, UK. Polaris Biopharma was founded in 1999 as a boutique patient recruitment and retention firm supporting global pharmaceutical companies.
buyer: ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals. ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology. "
target: Polaris Biopharma Consulting
Polaris Biopharma Consulting is a boutique patient recruitment and retention firm. Polaris has helped large and mid-sized pharmaceutical companies and CROs develop and deploy hundreds of global feasibility, trial optimisation and patient recruitment programs in every major therapeutic area.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2006 via BusinessWire

Applied Clinical Intelligence merged with TAKE Solutions, Inc.,

synopsis: TAKE Solutions, Inc. announced the formation of the OneClinical brand of life sciences offerings as part of its merger with Applied Clinical Intelligence and OnSphere Corporation. OneClinical combines a full spectrum of proven data and document management software products and services for clinical trials, drug and device development lifecycles.
buyer parent: Shriram Group
buyer: TAKE Solutions, Inc. (BSE:532890:$259.76)
TAKE Solutions is a leading international business technology company with products backed by a strong domain expertise to provide cost-effective comprehensive solutions for businesses. "
target: Applied Clinical Intelligence
Applied Clinical Intelligence was founded in 2001 to provide data-driven solutions for clinical trials and risk management programs. ACI is a specialized clinical services group offering strategic, operational, and technical intelligence.
price ($mm)
$4.71
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/9/2017 via PR Newswire

The WIRB-Copernicus Group, acquired ProPhase, LLC

synopsis: WIRB-Copernicus Group® (WCG™), the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, announced that it has acquired ProPhase. ProPhase is a global provider of measurement-related specialty solutions in clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: ProPhase, LLC
ProPhase is a global provider of measurement-related specialty solutions in clinical trials. For over a decade, ProPhase has focused on applying innovation to optimize the selection, use, and analysis of behavioral endpoints to mitigate trial risk and maximize the likelihood of study success.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/1/2005 via Company Press Release

Thomson Pharma, acquired Pharmaceutical Information Associates, Ltd.

synopsis: The Thomson Corporation announced that it has acquired Pharmaceutical Information Associates Ltd (PIA) and Astrolabe Analytica, Inc. (AAI). PIA and AAI are leading providers of regulatory consulting, marketing analytics and scientific communications services for the pharmaceutical industry.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma
Thomson Pharma is a dynamic, information offering for the pharmaceutical and biotechnology industries that is being developed by Thomson Scientific. "
target: Pharmaceutical Information Associates, Ltd.
Since 1990, Pharmaceutical Information Associates has supported the global drug development process by assisting with regulatory strategy development, the preparation of regulatory documentation, and the design, conduct, and audit of specialized clinical studies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via Company Press Release

Advarra, acquired Kinetiq

synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent: Linden Capital Partners
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/27/2013 via Company Press Release

PPD, Inc., acquired Acurian, Inc.

synopsis: Pharmaceutical Product Development, LLC, a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services, announced it has acquired Acurian, a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: Acurian, Inc.
Acurian, Inc. provides solutions needed to recruit, enroll, and retain patients for clinical trials. It offers recruitment feasibility, site identification and selection, patient recruitment and retention, and cancer solutions; and formulates a plan based on historical performance data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/5/2006 via PR Newswire

Ventiv Health, acquired Synergos, Inc.

synopsis: inVentiv Health, Inc. announced the completion of its acquisitions of Synergos, Inc., a focused clinical services provider, and Jeffrey Simbrow Associates Inc., Canada's leading healthcare marketing and communications agency. Both acquisitions were announced by inVentiv on March 13.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Synergos, Inc.
Synergos, Inc. is a functional service provider specializing in clinical trials management services, particularly project management and monitoring as well as investigator and patient recruitment. Synergos also provides regulatory affairs and quality compliance services.
price ($mm)
$5.75
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2014 via BusinessWire

Perficient, Inc., acquired BioPharm Systems, Inc.

synopsis: Perficient, Inc., a leading information technology consulting firm serving Global 2000 and other large enterprise customers throughout North America, announced it has acquired BioPharm Systems, Inc., a $15 million annual services revenue business and information technology consulting firm focused on the life sciences industry.
buyer: Perficient, Inc. (PRFT:$511.25)
Perficient is a leading information technology consulting firm serving Global 2000 and enterprise customers throughout North America. Perficient’s professionals serve clients from a network of offices across North America and three offshore locations, in Eastern Europe, India, and China. "
target: BioPharm Systems, Inc.
BioPharm Systems is a global IT consulting and managed services provider that focuses on the life sciences industry. BioPharm Systems has extensive experience in the implementation, integration, migration, upgrade, and hosting of clinical trial management, drug safety and pharmacovigilance and more.
price ($mm)
$18
rev ($mm)
$15
EBITDA ($mm)
EV / rev
1.2x
EV / EBITDA
closed 3/12/2014 via PR Web

d-Wise Technologies Inc., acquired Dootsonic Ltd.

synopsis: d-Wise Technologies, UK Ltd., announced that it has entered into an agreement to acquire Dootsonic Ltd., a privately-owned technology organization specializing in the support of the management, analysis and reporting of data from clinical trials.
buyer: d-Wise Technologies Inc.
d-Wise is a technology leader with the expertise to empower world-class life science and healthcare organizations to resolve their business optimization challenges, helping them rapidly harness and leverage data, systems and processes to gain competitive advantage. "
target: Dootsonic Ltd.
Dootsonic is a specialty technology consulting company, focused primarily on biometrics technology and process, providing high quality services for their clients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like RxSolutions


read more

RxSolutions

Market4care

American Imaging Management, Inc.

PokitDok Inc.

InstaMed

Heartland Payment Systems

mPay Gateway Inc.

Unified Payments

Discovery Health Partners

ABC Financial Services, Inc.

Secure Bill Pay

Patient Accounting Service Center, LLC

read more

RxSolutions

read more

Mango Health

RxSolutions

read more

CFS Clinical

Tri Stat

Phlexglobal

Phlexglobal

Adjility Health

Octagon Research Solutions, Inc.

Invicro, LLC

Wincere, Inc.

ACI Clinical

Synchrogenix Information Strategies, Inc.

Behavioral Health Care Associates, Ltd.

Polaris Biopharma Consulting

Applied Clinical Intelligence

ProPhase, LLC

Pharmaceutical Information Associates, Ltd.

Kinetiq

Acurian, Inc.

Synergos, Inc.

BioPharm Systems, Inc.

Dootsonic Ltd.

Geography
Matching Companies
Ticker: BSE:532890
 
 
 
 
 
 
 
 
TAKE Solutions, Inc.
TAKE Solutions, Inc.
TAKE Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management. Their range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums.
year
2018
rev ($mm)
$259.76
EBITDA ($mm)
$39.17
EBIT ($mm)
$33.43
Net Income ($mm)
$28.24
Employees
1500
  • drill down
  • watch
Ticker: WX
 
 
 
 
 
 
 
 
WuXi AppTec
WuXi AppTec
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States. WuXi AppTec provides a broad and integrated portfolio of services throughout the drug R&D process.
year
2014
rev ($mm)
$640.80
EBITDA ($mm)
$155.57
EBIT ($mm)
$108.53
Net Income ($mm)
$112.01
Employees
7445
  • drill down
  • watch
Ticker: AIM:C4XD
 
 
 
 
 
 
 
 
C4X Discovery
C4X Discovery aims to become the world’s most productive drug discovery and development company by exploiting cutting-edge technologies to design and create best-in-class drug candidates.
year
2015
rev ($mm)
$0.44
EBITDA ($mm)
($5.46)
EBIT ($mm)
($5.50)
Net Income ($mm)
Employees
19
  • drill down
  • watch
Ticker: XTRA:EVT
 
 
 
 
 
 
 
 
Evotec BioSystems GmbH
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.
year
2017
rev ($mm)
$226.46
EBITDA ($mm)
$53.38
EBIT ($mm)
$38.55
Net Income ($mm)
$40.69
Employees
1316
  • drill down
  • watch
Ticker: SYNH
 
 
 
 
 
 
 
 
INC Research, Inc.
INC Research, Inc.
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.
year
2018
rev ($mm)
$3,472.40
EBITDA ($mm)
$441.82
EBIT ($mm)
$157.52
Net Income ($mm)
Employees
21000
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: MCK
 
 
 
 
 
 
 
 
McKesson Corporation
McKesson Corporation
McKesson Corporation is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care.
year
2019
rev ($mm)
$214,319.00
EBITDA ($mm)
$4,229.00
EBIT ($mm)
$3,280.00
Net Income ($mm)
$34.00
Employees
70000
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2017
rev ($mm)
$3,467.64
EBITDA ($mm)
$637.81
EBIT ($mm)
$406.82
Net Income ($mm)
$252.97
Employees
34651
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch